Ovid Therapeutics | 4:持股变动声明-高管 LEVIN JEREMY M
Ovid Therapeutics | 4:持股变动声明-高管 Tardio Jason
Ovid Therapeutics | 4:持股变动声明-高管 Rona Jeffrey A
Ovid Therapeutics | 4:持股变动声明-董事 Poole Robert Michael
Ovid Therapeutics | 4:持股变动声明-高管 Perone Thomas Michael
Ovid Therapeutics | 4:持股变动声明-高管 LEVIN JEREMY M
Ovid Therapeutics | 4:持股变动声明-董事 Friedman Bart
Ovid Therapeutics | 4:持股变动声明-董事 Fitzgerald Kevin Joseph
Ovid Therapeutics | 4:持股变动声明-董事 Duncan Barbara Gayle
Ovid Therapeutics | 4:持股变动声明-董事 Bernstein Karen
Ovid Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Jeremy M. Levin(9.4%)
Ovid Therapeutics | 4/A:持股变动声明(修正)-高管 LEVIN JEREMY M
Ovid Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Madison Avenue International LP(5.2%),Madison Avenue Partners, LP(5.2%)等
Ovid Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Rubric Capital Management LP(7.52%),David Rosen(7.52%)
Ovid Therapeutics | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(6.1%)
Ovid Therapeutics | 4:持股变动声明-首席执行官 LEVIN JEREMY M
Ovid Therapeutics | SC 13G:超过5%持股股东披露文件-Madison Avenue International LP(5.1%),Madison Avenue Partners, LP(5.1%)等
Ovid Therapeutics | 4:持股变动声明
Ovid Therapeutics | 4:持股变动声明
Ovid Therapeutics | 4:持股变动声明
暂无数据